Article Details

Absci shares spike 30% in IPO debut, valuing Washington state biotech company at nearly $2B

Retrieved on: 2021-07-22 17:26:15

Tags for this article:

Click the tags to see associated articles and topics

Absci shares spike 30% in IPO debut, valuing Washington state biotech company at nearly $2B. View article details on hiswai:

Excerpt

... including Merck, and through the recent acquisition of synthetic biology company Totient and Denovium, a small deep learning startup that analyzes ...

Article found on: www.geekwire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up